Wellington Management Group LLP purchased a new stake in shares of Kyverna Therapeutics, Inc. ( NASDAQ:KYTX – Free Report ) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 117,442 shares of the company’s stock, valued at approximately $1,046,000.
Several other hedge funds have also recently added to or reduced their stakes in the company. Bank of America Corp DE purchased a new position in shares of Kyverna Therapeutics in the 2nd quarter worth about $2,365,000. Man Group plc purchased a new position in shares of Kyverna Therapeutics during the 2nd quarter valued at about $612,000. Canada Pension Plan Investment Board bought a new stake in Kyverna Therapeutics in the 2nd quarter worth approximately $356,000. Legal & General Group Plc bought a new stake in Kyverna Therapeutics in the 2nd quarter worth approximately $36,000. Finally, The Manufacturers Life Insurance Company purchased a new stake in Kyverna Therapeutics in the second quarter worth approximately $732,000. Institutional investors own 18.08% of the company’s stock.
Get Kyverna Therapeutics alerts: Analyst Upgrades and Downgrad...

